Target intelligence / Profile preview

ALG1 like 11, pseudogene (ALG1L11P)

Target: ALG1L11P
Molecular classification: Other (Pseudogene)

Overview

ALG1 like 11, pseudogene (ALG1L11P) is classified as a pseudogene in the human genome[3][5]. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but have lost the ability to encode a protein due to accumulated mutations[7]. As such, ALG1L11P does not produce a functional protein or have known biological or disease roles. It is not considered a therapeutic target, and there are no known drugs or mechanisms associated with it. Pseudogenes can sometimes be transcribed into RNA, but generally have no direct biological significance or therapeutic relevance[7].

Other names: asparagine-linked glycosylation 1-like 11, pseudogeneALG1L11P

Beyond the preview

Go deeper on ALG1 like 11, pseudogene (ALG1L11P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALG1 like 11, pseudogene (ALG1L11P).

Explore the full profile